Reference Group
Reference Group is an intervention with 8 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer
Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
Clinical Trials (8)
Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer
Bioequivalence Study of Fluvastatin Sodium Extended Release Tablets in Healthy Participants
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Gastrointestinal Tolerance of Infant Formula
All 8 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 8